Market Overview

FDA Issues Review of Hemispherx's Ampligen Lacks Required Carcinogencity Tests

Share:
Related HEB
12 Biggest Mid-Day Losers For Wednesday
Mid-Day Market Update: Dow Drops 100 Points; Matrix Service Shares Gain Following Earnings Beat

View document.

Posted-In: News FDA

 

Related Articles (HEB)

View Comments and Join the Discussion!